Venrock Adviser, LLC

Venrock Adviser, LLC reported 34 holdings worth US$2.06B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Venrock Adviser, LLC reported 34 holdings worth US$2.06B as of Sep 30, 2026. Largest: Oruka Therapeutics, Inc., Erasca, Inc. and Spyre Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
34
Value as reported
US$2.06B

The filing in full

CompanySharesValue as reported% of portfolio
Oruka Therapeutics, Inc.4.15MUS$346M16.8%
Erasca, Inc.20.1MUS$295M14.3%
Spyre Therapeutics, Inc.2.49MUS$221M10.8%
Savara, Inc.19.6MUS$101M4.9%
Ocular Therapeutix, Inc.10.3MUS$79.4M3.9%
Dianthus Therapeutics, Inc.822KUS$72.4M3.5%
Viridian Therapeutics, Inc.3.26MUS$67.1M3.3%
Vor Biopharma Inc.3.04MUS$58M2.8%
Cogent Biosciences, Inc.1.64MUS$52.6M2.6%
Adlai Nortye Group Ltd.3.21MUS$51.4M2.5%
Jade Biosciences, Inc.3.22MUS$45.2M2.2%
Achieve Life Sciences, Inc.5.5MUS$44.5M2.2%
Maze Therapeutics, Inc.1.55MUS$42M2.0%
ORIC Pharmaceuticals, Inc.2.94MUS$39.7M1.9%
Dyne Therapeutics, Inc.2.17MUS$35M1.7%
ADARx Pharmaceuticals, Inc.1.63MUS$32.4M1.6%
Crescent Biopharma, Inc.2.13MUS$31.1M1.5%
Relmada Therapeutics, Inc.7.45MUS$28.1M1.4%
Zura Bio Limited6.43MUS$26.8M1.3%
X4 Pharmaceuticals, Inc.7.64MUS$22.2M1.1%
Cullinan Therapeutics, Inc.1.38MUS$21.2M1.0%
Surrozen, Inc.633KUS$20.4M0.99%
Parabilis Medicines, Inc.625KUS$20.2M0.98%
Arvinas, Inc.1.95MUS$15.1M0.73%
Century Therapeutics, Inc.8.7MUS$14.9M0.72%
Artiva Biotherapeutics, Inc.2.04MUS$14.6M0.71%
Alto Neuroscience, Inc.500KUS$12.8M0.62%
Korro Bio, Inc.443KUS$4.39M0.21%
TCGX Acquisition Corp.300KUS$3.75M0.18%
Research Alliance Corporation IV300KUS$3.6M0.17%
InMed Pharmaceuticals Inc.133KUS$181K<0.01%
Apogee Therapeutics, Inc.0US$00.00%
Cybin, Inc.0US$00.00%
CytomX Therapeutics, Inc.0US$00.00%
Damora Therapeutics, Inc.0US$00.00%
Enliven Therapeutics, Inc.0US$00.00%
Research Alliance Corporation III0US$00.00%

Source

Download original · View original at SEC

Related